Haixiong Han

Title: Haixiong Han: Innovator in Tumor Treatment

Introduction

Haixiong Han is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in tumor treatment and diagnosis. With a total of 2 patents, Han's work focuses on the applications of specific human genes in medical therapies.

Latest Patents

Han's latest patents include innovative uses of the human ZFX gene and the NLK gene. The first patent discloses the uses of the human ZFX gene and associated drugs, highlighting its potential in tumor treatment, diagnosis, and drug preparation. The invention details how small interfering RNA (siRNA) and lentiviruses can specifically inhibit the expression of the ZFX gene, promoting tumor apoptosis and significantly impacting tumor treatment.

The second patent focuses on the human NLK gene, outlining its applications in similar areas. This invention constructs an isolated molecule that attenuates the expression of the NLK gene in tumor cells. The use of a NLK interference lentivirus is also disclosed, which can effectively infect target cells and inhibit tumor growth, showcasing its importance in cancer therapies.

Career Highlights

Haixiong Han is associated with Shanghai Genechem Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.

Collaborations

Han collaborates with notable colleagues, including Xiangying Zhu and Yangsheng Jin, who contribute to his research endeavors.

Conclusion

Haixiong Han's innovative work in the field of biotechnology, particularly regarding tumor treatment, demonstrates his commitment to advancing medical science. His patents reflect a significant step forward in the application of genetic research to combat cancer.